In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: A critical role for tissue macrophages

Citation
M. Grinsell et al., In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: A critical role for tissue macrophages, J INFEC DIS, 184(4), 2001, pp. 479-487
Citations number
50
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF INFECTIOUS DISEASES
ISSN journal
00221899 → ACNP
Volume
184
Issue
4
Year of publication
2001
Pages
479 - 487
Database
ISI
SICI code
0022-1899(20010815)184:4<479:IVCOGT>2.0.ZU;2-H
Abstract
Cryptococcus neoformans produces a life-threatening meningitis in patients who are immunocompromised by AIDS. A striking feature of cryptococcosis in AIDS is high serum levels of the major capsular polysaccharide, glucuronoxy lomannan (GXM). Soluble GXM has numerous biologic activities that may contr ibute to the pathogenesis of infection. The objective of the study was to f urther understand in vivo processing of GXM. Mice were injected intravenous ly with GXM, and the tissue distribution was determined. A macrophage suici de technique that used liposome-encapsulated dichloromethylene diphosphonat e determined the role of macrophages. GXM was cleared from serum with a hal f-life of 24-48 h but was retained for an indefinite period in tissues rich in cells of the mononuclear phagocyte system. Ablation of macrophages decr eased GXM in the liver and spleen and increased serum GXM. The results iden tify a key role for macrophages in the clearance of GXM from serum and iden tify macrophages as a long-term reservoir for storage.